We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
22 hedge funds and large institutions have $52.6M invested in Fate Therapeutics in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
16% less capital invested
Capital invested by funds: $62.4M → $52.6M (-$9.83M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
3
Increased
11
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
KCM
Kingdon Capital Management
New York
|
+$1.33M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$135K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$133K |
| 5 |
Goldman Sachs
New York
|
+$91.5K |
